Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-28

Clinical Trial Update: Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

View source ↗

Summary

This completed retrospective cohort study evaluated ALT changes after initiation of antidiabetic therapy in adults with type 2 diabetes, including those with fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus), Fatty Liver | Status: COMPLETED